Intravenous neridronate is effective in regional migratory osteoporosis
Rheumatology (Oxford)
.
2022 Oct 6;61(10):e311-e313.
doi: 10.1093/rheumatology/keac289.
Authors
Roberto D'Alessandro
1
,
Paolo Falsetti
1
,
Marco Bardelli
1
,
Stefano Gentileschi
1
,
Caterina Baldi
1
,
Edoardo Conticini
1
,
Luca Cantarini
1
,
Bruno Frediani
1
Affiliation
1
Rheumatology Unit-Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
PMID:
35567485
DOI:
10.1093/rheumatology/keac289
No abstract available
MeSH terms
Diphosphonates* / therapeutic use
Humans
Osteoporosis* / drug therapy
Substances
Diphosphonates
6-amino-1-hydroxyhexane-1,1-diphosphonate